Click Here for 5% Off Your First Aladdin Purchase!

Itepekimab (anti-IL-33) - Primary antibody, specific to IL33, >95%, high purity, Human IgG4SP, INHIBITOR of Interleukin-33 inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Cynomolgus monkey,Human
  • Isotype: Human IgG4SP
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab177904
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab177904-100μg
100μg
In stock
$69.90
Ab177904-1mg
1mg
In stock
$339.90
Ab177904-5mg
5mg
In stock
$859.90
Ab177904-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,369.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

View related series
Accession#:O95760 Gene ID:90865 IL33

Basic Description

Product NameItepekimab (anti-IL-33) - Primary antibody, specific to IL33, >95%, high purity, Human IgG4SP
SynonymsC9orf26 antibody; CHROMOSOME 9 OPEN READING FRAME 26 antibody; DKFZp586H0523 antibody; DVS27 antibody; DVS27 related protein antibody; IL 1F11 antibody; IL 33 antibody; IL-1F11 antibody; IL-33 antibody; IL1F11 antibody; IL33 antibody; IL33_HUMAN antibody;
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityIL33
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Interleukin-33 inhibitor
Product Description

Itepekimab (anti-IL-33) is a monoclonal antibody of IL-33. Itepekimab (anti-IL-33) reduces airway inflammation and related tissue damage in previous clinical studies. Itepekimab (anti-IL-33) has potential application in asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis (AD).

Product Properties

IsotypeHuman IgG4SP
Light Chain Typekappa
SDS-PAGE26.2 kDa (Light Chain) & 51.8 kDa (Heavy Chain), under reducing conditions; 195.4 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2226742-52-3

Images

Itepekimab (anti-IL-33) (Ab177904) - ELISA
Immobilized Recombinant Human IL-33 Protein (rp169652) at 2.0 μg/mL can bind Itepekimab (anti-IL-33) (Ab177904) with the EC₅₀ of 45.69 ng/mL.

Itepekimab (anti-IL-33) (Ab177904) - SEC
The purity of Itepekimab (anti-IL-33) (Ab177904) is more than 95% verified by HPLC.

Associated Targets

IL33 Tbio Interleukin-33 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0404223Certificate of AnalysisApr 08, 2024 Ab177904
ZJ24F0404222Certificate of AnalysisApr 08, 2024 Ab177904
ZJ24F0404221Certificate of AnalysisApr 08, 2024 Ab177904

Related Documents

References

1. Osbourn M, Soares DC, Vacca F, Cohen ES, Scott IC, Gregory WF, Smyth DJ, Toivakka M, Kemter AM, le Bihan T et al..  (2017)  HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33..  Immunity,  47  (4): (739-751.e5).  [PMID:29045903]
2. Onda, H H and 7 more authors..  (1999)  Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage..  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,      [PMID:10566975]
3. Baekkevold, Espen S ES and 9 more authors..  (2003)  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules..  The American journal of pathology,      [PMID:12819012]
4. Carriere, Virginie V and 7 more authors..  (2007)  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo..  Proceedings of the National Academy of Sciences of the United States of America,    (2):   [PMID:17185418]
5. Komai-Koma, Mousa M and 5 more authors..  (2007)  IL-33 is a chemoattractant for human Th2 cells..  European journal of immunology,      [PMID:17853410]
6. Küchler, Axel M AM and 8 more authors..  (2008)  Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation..  The American journal of pathology,      [PMID:18787100]
7. Moussion, Christine C, Ortega, Nathalie N and Girard, Jean-Philippe JP..  (2008)  The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?.  PloS one,    (6):   [PMID:18836528]
8. Cayrol, Corinne C and Girard, Jean-Philippe JP..  (2009)  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1..  Proceedings of the National Academy of Sciences of the United States of America,    (2):   [PMID:19439663]
9. Talabot-Ayer, Dominique D, Lamacchia, Céline C, Gabay, Cem C and Palmer, Gaby G..  (2009)  Interleukin-33 is biologically active independently of caspase-1 cleavage..  The Journal of biological chemistry,    (17):   [PMID:19465481]
10. Lüthi, Alexander U AU and 11 more authors..  (2009)  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases..  Immunity,    (17):   [PMID:19559631]
11. Hayakawa, Morisada M and 5 more authors..  (2009)  Mature interleukin-33 is produced by calpain-mediated cleavage in vivo..  Biochemical and biophysical research communications,    (11):   [PMID:19596270]
12. Lingel, Andreas and 7 more authors..  (2009)  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes..  Structure (London, England : 1993),    (14):   [PMID:19836339]
13. Hong, Jaewoo J and 10 more authors..  (2011)  Identification of constitutively active interleukin 33 (IL-33) splice variant..  The Journal of biological chemistry,    (3):   [PMID:21454686]
14. Ali, Shafaqat S and 6 more authors..  (2011)  The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription..  Journal of immunology (Baltimore, Md. : 1950),    (15):   [PMID:21734074]
15. Kakkar, Rahul R, Hei, Hillary H, Dobner, Stephan S and Lee, Richard T RT..  (2012)  Interleukin 33 as a mechanically responsive cytokine secreted by living cells..  The Journal of biological chemistry,    (24):   [PMID:22215666]
16. Liu, Xi X and 7 more authors..  (2013)  Structural insights into the interaction of IL-33 with its receptors..  Proceedings of the National Academy of Sciences of the United States of America,    (10):   [PMID:23980170]

Solution Calculators